Edenbridge Pharmaceuticals Selects PANTHERx Rare and Orsini Specialty Pharmacy to Distribute Yargesa to Treat Gaucher Disease
Pyros Pharmaceuticals Selects Anovo as Exclusive Distributor and Specialty Pharmacy For VIGPODER to Treat Infantile Spasms
The following company announcements are just a few of the specialty pharmacy company activities from this month. Subscribe to AMI’s Specialty Pharmacy Database to stay up to date on company and industry trends
Zilbrysq is available through the specialty pharmacy PANTHERx Rare Pharmacy and through a Risk Evaluation and Mitigation Strategy (REMS) program because of the risk of serious meningococcal infections.
Independence Blue Cross and Sun Life U.S. collaborate to provide Stop Loss insurance for Independence’s self-funded group customers
Employers’ benefit coverage decisions and the impact those decisions have on the market for rare disease / orphan drugs are a growing concern for biopharma companies
Independence Blue Cross (Independence) recently announced the launch of its Advanced Network for Gene-Based Therapeutics, which will be effective March 1, 2023
The leading specialty pharmacies were busy signing limited distribution drug agreements at the end of 2022. Here’s a round-up of the activities